Innoviva, Inc. (INVA)
NASDAQ: INVA · IEX Real-Time Price · USD
15.26
+0.27 (1.80%)
Apr 26, 2024, 4:00 PM EDT - Market closed

Innoviva Revenue

In the year 2023, Innoviva had annual revenue of $310.46M, a decrease of -6.30%. Revenue in the quarter ending December 31, 2023 was $85.84M with 30.45% year-over-year growth.

Revenue (ttm)
$310.46M
Revenue Growth
-6.30%
P/S Ratio
3.11
Revenue / Employee
$2,771,991
Employees
112
Market Cap
964.85M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023310.46M-20.88M-6.30%
Dec 31, 2022331.34M-60.53M-15.45%
Dec 31, 2021391.87M55.07M16.35%
Dec 31, 2020336.79M75.78M29.03%
Dec 31, 2019261.02M12.00K0.00%
Dec 31, 2018261.00M43.79M20.16%
Dec 31, 2017217.22M83.65M62.63%
Dec 31, 2016133.57M79.62M147.58%
Dec 31, 201553.95M45.52M539.74%
Dec 31, 20148.43M3.90M86.08%
Dec 31, 20134.53M-1.08M-19.26%
Dec 31, 20125.61M-18.90M-77.10%
Dec 31, 201124.51M289.00K1.19%
Dec 31, 201024.22M-151.00K-0.62%
Dec 31, 200924.37M1.28M5.53%
Dec 31, 200823.10M1.09M4.97%
Dec 31, 200722.00M2.42M12.33%
Dec 31, 200619.59M7.53M62.49%
Dec 31, 200512.05M3.11M34.83%
Dec 31, 20048.94M5.34M147.99%
Dec 31, 20033.61M3.45M2,210.90%
Dec 31, 2002156.00K--
Dec 31, 20010--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Alignment Healthcare 1.82B
BioCryst Pharmaceuticals 331.41M
MiMedx Group 321.48M
Standard BioTools 106.34M
Cronos Group 87.24M
Simulations Plus 64.67M
Bicycle Therapeutics 26.98M
Liquidia 17.49M
Revenue Rankings